Maat Pharma SA (MAAT) — Strategic Asset Allocation Index

Maat Pharma SA (MAAT) has a Strategic Asset Allocation Index of 83.2% as of December 2024. Strategic assets (PP&E of €8.60 Million plus long-term investments of €-) total €8.60 Million, measured against net assets of €10.34 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MAAT equity financing ratio to measure how much of total assets are equity-financed.